Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Intensity Therapeutics Inc. (INTS) had Debt to Capital Ratio of 0.01 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.67M |
|
-- |
|
-- |
|
$2.73M |
|
$-2.73M |
|
$0.06M |
|
$-2.67M |
|
$-2.67M |
|
$-2.67M |
|
$-2.67M |
|
$-2.67M |
|
$-2.67M |
|
$-2.73M |
|
$-2.73M |
|
43.04M |
|
43.04M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$8.19M |
|
-- |
|
$1.40M |
|
$9.59M |
|
$2.28M |
|
$0.09M |
|
$0.09M |
|
$2.36M |
|
$7.22M |
|
$7.22M |
|
$7.22M |
|
49.07M |
|
| Cash Flow Statement Financials | |
$-6.83M |
|
-- |
|
$11.31M |
|
$2.59M |
|
$7.07M |
|
$4.48M |
|
$1.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.60 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.01 |
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-36.98% |
|
-36.98% |
|
-27.87% |
|
-36.54% |
|
$0.15 |
|
$-0.16 |
|
$-0.16 |
|